Published • loading... • Updated
Hipra Bills 17% More and Accelerates in Human Health with Its Vaccines
Summary by Expansión
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Hipra, a pharmaceutical specialist in vaccination and prevention based in Amer (Girona), regained growth in 2025 after the impact of its division a year before...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
